Can (and will) governments afford personalized medicine?

Personalized Medicine
David Taylor, Eman Al-Saeed

Abstract

'Personalized' (or more specifically targeted) medicines promise aging populations important medium- to long-term benefits, including extended healthy life expectancies. But the time and resources needed to deliver such advances may be significantly greater than optimists expect. Given current methodologies, drugs for limited numbers of older patients are also much less likely to be judged cost effective than treatments for more common conditions in younger populations. There is a consequent danger that private and public funding for personalized medicine development will in the future fall to a level that is significantly below the global public's best interests. Policy-makers should be aware of this risk, and take actions to mitigate it. These include minimizing the costs and complexities associated with marketing personalized medicines and linked diagnostic tests, as well as strengthening intellectual property protection in ways that will allow 'rich world' pharmaceutical price moderation, increased innovator security and enhanced treatment access for poorer populations.

References

Apr 8, 2004·The Pharmacogenomics Journal·J Tang, R A Kaslow
Jan 26, 2005·Journal of Health Services Research & Policy·David MelzerRon Zimmern
Nov 23, 2005·The Pharmacogenomics Journal·B S Shastry
Nov 30, 2005·The Pharmacogenomics Journal·A WoelderinkE Rodriguez-Cerezo
Feb 9, 2007·Sociology of Health & Illness·David Taylor, Michael Bury
Jan 15, 2008·Drug Discovery Today·Janice M Reichert, Julia B Wenger
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Amy L McGuire, Wylie Burke
Dec 25, 2008·The New England Journal of Medicine·Jessica L MegaMarc S Sabatine
Jan 29, 2009·Nature Clinical Practice. Oncology·Christine M Walko, Howard McLeod
Feb 21, 2009·The New England Journal of Medicine·UNKNOWN International Warfarin Pharmacogenetics ConsortiumJ A Johnson
May 8, 2009·The New England Journal of Medicine·Alan M Garber, Sean R Tunis
Nov 26, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Geoffrey S Ginsburg, Huntington F Willard
Dec 2, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C La VecchiaF Levi
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David MarinJamshid S Khorashad
Jan 1, 2010·Ecancermedicalscience·P KanavosZ Vlachopioti
Mar 1, 2010·Personalized Medicine·Brigette By Ma, Herbert Loong

❮ Previous
Next ❯

Citations

Jan 1, 2017·Personalized Medicine·Sebastian Schee Genannt HalfmannAngela Brand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.